Royal jelly

Royal jelly is marketed as a «longevity secret» and «youth elixir», invoking the lifespan difference between worker bees and the queen. This argument is biologically wrong: the difference reflects the genetic programme of a social insect, not a transferable human effect. RCTs of longevity and age-related mortality reduction with royal jelly do not exist. Proven methods to extend active life are smoking cessation, Mediterranean diet, physical activity, control of blood pressure, cholesterol and diabetes (USPSTF, AHA, ESC). Royal jelly is not in these guidelines. Given the high allergen risk, the «rejuvenation» idea creates a real chance of anaphylactic shock instead of the promised youth. If royal jelly was bought «for longevity», discuss with a doctor; basic prevention and regular monitoring work – the bee secretion does not.

Royal jelly is marketed as an «anti-aging panacea», «immune booster», «women's hormone product», «vital energy» and «eternal youth of the bee queen». None of these claims is supported by human RCTs. EFSA in 2011 rejected all royal jelly health claims – the Panel concluded that a cause-and-effect relationship between consumption and claimed effects is not established. The «hormone of youth» concept is biologically illiterate: 10-HDA and MRJP have no mammalian receptors and the «queen rejuvenation» effect is an insect-development feature not transferable to humans. The main clinical issue is not lack of benefit but real allergy risk: royal proteins cause severe IgE-mediated reactions with reported deaths from anaphylaxis and severe asthma (Thien 1996, Leung 1997). If royal jelly was bought for «general health», discuss with a doctor; the risk outweighs any hypothetical benefit.